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ABSTRACT Monomeric a-synuclein (aSN), which has no persistent structure in aqueous solution, is known to bind to anionic
lipids with a resulting increase in a-helix structure. Here we show that at physiological pH and ionic strength, aSN incubated with
different anionic lipid vesicles undergoes a marked increase in a-helical content at a temperature dictated either by the temper-
ature of the lipid phase transition, or (in 1,2-DilauroylSN-Glycero-3-[Phospho-rac-(1-glycerol)] (DLPG), which is ﬂuid down to
0C) by an intrinsic cold denaturation that occurs around 10–20C. This structure is subsequently lost in a thermal transition
around 60C. Remarkably, this phenomenon is only observed for vesicles >100 nm in diameter and is sensitive to lipid chain
length, longer chain lengths, and larger vesicles giving more cooperative unfolding transitions and a greater degree of structure.
For both vesicle size and chain length, a higher degree of compressibility or permeability in the lipid thermal transition region is
associated with a higher degree of aSN folding. Furthermore, the degree of structural change is strongly reduced by an increase
in ionic strength or a decrease in the amount of anionic lipid. A simple binding-and-folding model that includes the lipid phase
transition, exclusive binding of aSN to the liquid disordered phase, the thermodynamics of unfolding, and the electrostatics of
binding of aSN to lipids is able to reproduce the two thermal transitions as well as the effect of ionic strength and anionic lipid.
Thus the nature of aSN’s binding to phospholipid membranes is intimately tied to the lipids’ physico-chemical properties.INTRODUCTION
The 140-residue a-synuclein (aSN) protein is a central player
in the etiology of Parkinson’s disease. The protein, although
natively unfolded in buffer as a monomer, aggregates to higher
order structures in a series of events that ultimately leads to
amyloid fibrils (1). An early stage oligomer appears to be
implicated in cytotoxicity, as it is able to bind to anionic phos-
pholipid membranes in vivo and induce uncontrolled permea-
bilization of small molecules such as Ca2þ ions (2–4). In vivo
oligomers can also induce extracellular influx of Ca2þ and
induction of apoptosis (5). The exact nature of the oligomer
is still unresolved. Different incubation conditions lead to
different types of oligomers with markedly different biolog-
ical properties (5). Nevertheless, interactions with lipids are
central to the protein’s cytotoxicity and are most likely central
to its as yet unidentified function(s). Endogenous aSN may
regulate synaptic vesicle mobilization at nerve terminals (6).
In yeast, genes involved in vesicle-mediated transport and
lipid metabolism modify aSN toxicity (7); aSN overexpres-
sion in yeast interferes with ER-Golgi traffic and can be
rescued by a protein (Rab1) involved in the same type of
vesicle transport (8). Lipid binding and formation of a-helical
structure inhibits fibril formation (9). The familial Parkinson’s
disease (PD) mutant A30P shows lower lipid affinity than
wild-type aSN (10–13) and a concomitant reduction in a-hel-
icity (14). This reduced binding affinity may be related to the
mutant’s inability to provide the same protective effect as
wild-type aSN in mice lacking the CSP-a gene (15). Better
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0006-3495/09/04/2857/14 $2.00insight into interactions between lipids and aSN monomers
may also provide clues as to the protein’s biological function.
Although cytoplasmic components may enhance aSN
interactions with lipids and thus reduce the sensitivity of the
interaction to changes in ionic strength (16), there is a large
body of evidence supporting the direct interaction between
aSN and lipids. As seen for many other flexible proteins, the
fluctuating and dynamic nature of aSN (17) makes its struc-
ture highly sensitive to changes in pH, ionic strength, and
charged amphiphiles. Thus, anionic lipid vesicles (11,
18–21), polyunsaturated fatty acids (22), and anionic detergents
such as sodium dodecyl sulfate (18) induce a-helical structure
in aSN, though it remains disputed whether the a-helicity
observed in anionic vesicles is caused by a single unbroken
helix (23,24) or by a bent helix leading to an antiparallel
arrangement (25,26). Furthermore, fatty acids encourage the
formation of soluble aSN oligomers in vivo (27,28). Binding
of anionic amphiphiles is probably mediated by attractions to
positively charged amino acids, given the preponderance of
positive charges in the first 102 residues of aSN; in addition,
fatty acid binding motifs have been suggested to occur in
both termini (27). For anionic lipids, aSN shows preferential
binding to smaller vesicles (25 nm diameter) rather than larger
vesicles (125 nm diameter), probably because binding is facil-
itated by lipid packing defects (29). Interactions with anionic
lipids predominantly occur at the interface in the liquid disor-
dered phase according to electron paramagnetic resonance
(EPR)-based temperature scans (30). This preference for the
liquid disordered phase, corroborated by confocal laser scan-
ning microscopy (13), no doubt reflects that the lipid interface
has to be able to rearrange to accommodate the protein.
doi: 10.1016/j.bpj.2008.12.3940
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anionic membranes (3,31,32), probably because embedding
in the upper part of the membrane (30,33,34) disrupts the
membrane organization, analogous to antimicrobial peptides.
However, there are numerous indications that aSN can
interact with lipids in many different ways. aSN also binds
to small zwitterionic vesicles in the gel phase but not liquid
disordered phase (35), and aSN binding to small vesicles is
encouraged by lipid phase separation induced by the presence
of lipids of different chain lengths (19). This suggests a role
for annealing defects in curved membranes and thus prevent
premature fusion of synaptic vesicles (36). Interestingly, the
presence of the zwitterionic phosphoethanolamine (in combi-
nation with anionic lipids) and a transmembrane potential
induces ion channels with well-defined conductance states
(37). All these observations suggest that many aspects of
aSN-lipid interactions remain to be elucidated in detail.
Here we report an unusual ability of aSN to bind to large
anionic vesicles and undergo reversible structural changes as
a function of temperature. The structural changes show
strong dependence on lipid/protein ratios, lipid-melting
temperatures, ionic strength, lipid charge, and vesicle size.
We have developed a thermodynamic model that captures
many of these tendencies and shows that aSN interaction
with lipids can be understood on the basis of simple mass
action relations, coupled with cold and heat denaturation
and lipid phase transitions. The model does not attempt to
capture the reliance on a minimum vesicle size or the corre-
lation between induced structure and chain length, but we
suggest that these phenomena are qualitatively related to
specific lipid properties in the phase transition region.
MATERIALS AND METHODS
aSN was expressed and purified as described (38). Protein concentration
was determined using an extinction coefficient of 5120 M1 cm1. 1,2-Dio-
leoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (DOPG); 1,2-Dioleoyl-sn-
Glycero-3-Phosphocholine (DOPC); 1,2-Dilauroyl-sn-Glycero-3-[Phospho-
rac-(1-glycerol)] (DLPG); 1,2-Dilauroyl-sn-Glycero-3-Phosphocholine
(DLPC); 1,2-Dimyristoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (DMPG);
1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC); 1,2-Dimyristoyl-sn-
Glycero-3-Phosphoethanolamine (DMPE); 1,2-Dipalmitoyl-sn-Glycero-3-
[Phospho-rac-(1-glycerol)] (DPPG); and 1,2-Dipalmitoyl-sn-Glycero-3-Phos-
phocholine (DPPC) were from Avanti Polar Lipids (Alabaster, AL). All exper-
iments were carried out in PBS buffer (10 mM sodium phosphate (pH 7.4) and
150 mM NaCl), unless otherwise stated. Single-component vesicles were sus-
pended in buffer, subjected to five freezing-thawing cycles and extruded
through filters of different pore sizes as described (39). For double-component
vesicles, the lipids were first mixed in powder form, dissolved in chloroform,
then dried and prepared as described above.
Circular dichroism spectra and thermal scans were performed on a Jasco
J-810 spectrophotometer (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan)
using a 1-mm cuvette. Unless otherwise stated, both protein and lipid concen-
trations were 0.2 mg/mL (28mM protein and 250–310mM lipid, depending on
the lipid used). Wavelength scans (250–190 nm) were recorded with a scan
speed of 50 nm/min and five accumulations. Temperature scans were moni-
tored at 215 nm with a scanning speed of 90C/h in steps of 0.2 nm.
A note on reproducibility of thermal far-UV circular dichroism (CD)
scans: For all lipids, the overall shape of the thermal scan is always retainedBiophysical Journal 96(7) 2857–2870from one experiment to the next, and the different transition temperatures
vary by <1C between triplicate measurements. We see some variation
(~50%) in the slopes of the different plateau regions, whose ellipticity values
vary by around 20% (data not shown). This variation is probably due to
subtle changes in lipid vesicle size distributions that show natural variation
from one preparation to the next. The variations are significantly smaller for
experiments performed with the same vesicle batch.
Differential scanning experiments were performed on a VP-differential
scanning calorimeter (MicroCal, Northampton, MA) using 1 mg/mL protein
and 1 mg/mL lipid. A 0.7 mL sample and buffer reference were degassed in
a vacuum chamber and thermal scans were done with low or no feedback,
a scan rate of 60C/h and a 0.16C step size. Between runs, the calorimeter
was cleaned by washing with 1% Mucasol, ethanol, and milliQ water for
10 min with each using a vacuum pump with the cleaning solution in the loop.
RESULTS AND DISCUSSION
aSN shows two characteristic thermal transitions
in anionic lipids
When aSN is incubated with equal amounts (weight/weight)
of 200-nm extruded vesicles of DMPG in the gel phase at 1C,
it retains the far-UV CD spectrum characteristic of a random
coil (Fig. 1 A). However, as the temperature increases, the
spectrum changes to that of a predominantlya-helical species,
with two minima around 222 and 209 nm. The ellipticity
(monitored midway between the two minima at 215 nm in
Fig. 1 B) reaches its greatest value around 35C (midpoint
around 25C), and then starts to decrease slowly in magni-
tude, rising steeply above 54C to a new plateau from
~66C onwards, with a midpoint around 61C. All spectra
between 1C and 65C show an isodichroic point around
203 nm, suggesting that both the downward transition and
most of the upward transition represent a simple two-state
transition from random coil to predominantly a-helical and
back. Above 65C, there is no longer any isodichroic point,
suggesting that we are monitoring another structural change
at this stage. Consistent with this observation, all of the tran-
sitions are completely reversible if the temperature does not
exceed 60–65C (the end of the second major transition), as
repeated upward and downward cycles, as well as scans
carried out at scan rates between 10C and 90C, lead to
superimposable scans (data not shown). There is essentially
no change if we ‘‘jump in’’ by preincubating at a certain
temperature (e.g., the plateau between the two transitions)
and then proceed with a temperature rise. Thus the system
immediately adjusts to the temperature in question, in good
accord with the complete reversibility of the process up to
65C. At higher temperatures we cannot exclude the forma-
tion of covalent modifications or irreversible aggregation
(see below). Similar isodichroic points at 203 nm up to
~65C are seen for DLPG and DPPG (data not shown).
aSN undergoes the same type of transition in the anionic
lipids DLPG and DPPG (Fig. 1 B), although the downward
transition is shifted to higher temperatures in DPPG
(midpoint around 40C) and to lower temperatures in
DLPG (midpoint around 10C). For DLPG, DMPG, and
DPPG, the midpoint corresponds reasonably to the phase
a-Synuclein Stability in Vesicles 2859-16
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FIGURE 1 (A) Thermal far-UV CD scans of 0.2 mg/mL aSN in 0.2 mg/mL 200-nm DMPG vesicles as a function of increasing temperature. (B) Thermal
far-UV CD scans at 215 nm for 0.2 mg/mL aSN in 0.2 mg/mL 200-nm vesicles of different lipids. For clarity, data have been offset for three lipids by the
following number of units: DOPG þ 4, DLPG þ 2, and DPPG  6. (C) Linear correlation between melting temperature tm of the lipids and the molar ellipticity
of the plateau following this transition (solid circles). A linear correlation is also seen between tm and the log of the slope of this transition (open circles). Error
bars represent estimates of 20% errors from plateau scans and 10% from slopes from triplicate experiments. (D) Differential scanning calorimetry scan of aSN
in DMPG (solid line) contrasted with the corresponding far-UV CD scan (stippled line) from (B). DSC scans were with 1 mg/mL aSN in 1 mg/mL lipid
whereas CD scans were with 0.2 mg/mL aSN in 0.2 mg/mL lipid. (E) Thermal far-UV CD scans of 0.2 mg/mL aSN in 0.2 mg/mL DMPG as a function
of extruded vesicle size. Notice the complete disappearance of distinct thermal transitions for vesicles with diameters below 200 nm.Biophysical Journal 96(7) 2857–2870
2860 Kjaer et al.change at temperature tm where the lipid goes from the gel
phase (below tm) to the liquid disordered phase (above tm).
However, the steepness of this transition markedly increases
from DLPG and DOPG as we go to DMPG and DPPG. Simi-
larly, the upward transition is much steeper in DMPG (steep
curve from 57C to 67C) and DPPG (steep curve from 55C
to 61C) than in DLPG (steep curve from 52C to 72C),
indicating that the cooperativity of the transition increases
with increasing lipid transition temperature tm. In the 18-
carbon unsaturated lipid DOPG, by contrast, both transitions
are smoothed out and hardly visible (Fig. 1 B). The degree
of a-helicity attained by aSN at the end of the downward
transition correlates linearly with tm (Fig. 1 C). The same
insert also illustrates a linear correlation between the slope
of the downward transition and tm. Similar types of correla-
tion exist between tm and the slope and plateau level associ-
ated with the upward transition (data not shown).
Both transitions in DMPG are also seen as classical
enthalpic peaks by differential scanning calorimetry (DSC)
(Fig. 1 D). There is a slight shift in the second transition,
which peaks around 68C, around 6C higher than that in
CD, but this can be attributed to the somewhat higher lipid
concentrations required for DSC measurements (1 mg/mL)
versus CD (0.2 mg/mL).
Importantly, these two transitions are very sensitive to
vesicle size. In the great majority of our experiments, they
are not observed in far-UV CD thermal scans for DMPG vesi-
cles smaller than around 200 nm (Fig. 1 E). If vesicles smaller
than 200 nm are cooled down below the tm, they coalesce to
larger structures that are able to induce structure in aSN
upon subsequent heating (data not shown). Higher concentra-
tions (1 mg/mL and above) of 100-nm vesicles led to more
distinct transitions that gradually approached those of the
200-nm vesicles in terms of ellipticity values, indicating
a difference in affinity between the two classes of vesicles
(data not shown). However, nonextruded vesicles (which
have sizes from several hundred nm up to a few mm) show
the same behavior as 200-nm vesicles (data not shown).
The thermal transitions are not artifacts of lipid
networks but represent genuine protein
conformational changes
We suspected that these transitions might be artifacts of lipid
reorganization rather than protein structural changes. At low
salt concentrations, anionic lipids are known to form exten-
sive bilayer networks (40), which could lead to light-scat-
tering artifacts. However, this effect is effectively screened
by increasing salt and effectively disappears around physio-
logical salt concentrations, such as those used in our study
(150 mM NaCl). In addition, we have accumulated several
other observations that argue against a simple lipid-based
artifact rather than a genuine induction of structure.
First, the transitions are not seen when lipids are incubated
in the absence of protein (data not shown) or even in theBiophysical Journal 96(7) 2857–2870presence of a membrane-interacting protein such as the anti-
microbial peptide Novispirin, which is known to have a pref-
erence for anionic lipids (39) (Fig. 2 A). They do not occur
when aSN is heated in the absence of lipid (Fig. 2 A).
Dynamic light-scattering experiments do not indicate signifi-
cant vesicle changes over the measured temperature range
(data not shown). In addition, in mixtures of DOPG with
DMPG or DLPG, where the lipid thermal transitions are
altered, the observed transitions correspond to those seen in
neat DMPG or DLPG (see below). Second, and in even
greater contrast to the lipid network transition (40), the aSN
transitions in DMPG also occur well above 150 mM NaCl
(Fig. 2 B), although the amount of structure induced by the
first transition decreases markedly with increasing salt
concentration, suggesting that the interactions with DMPG
are mediated by electrostatic interactions. The midpoints of
both the low- and high-temperature transitions, as well as
the plateau levels between the transitions, scale linearly
with the square root of the ionic strength, which is a measure
of the solution’s screening ability (Fig. 2 C). The shift in
midpoint is much more pronounced for the high-temperature
transition. The two transitions converge toward each other
and merge around 600 mM NaCl.
Third, and probably most importantly, we see significant
differences compared to wild-type aSN when we measure
thermal far-UV CD scans using two naturally occurring
mutant variants of aSN, namely A30P and A53T (Fig. 2 D),
which differ in their lipid binding affinities (12) and their
amount of residual structure compared to wild-type (14).
All three proteins show the same low-temperature transition
around 20C (governed by the lipid transition, see below),
but there is a marked variation in the high-temperature transi-
tion. A30P, which shows decreased affinity for membranes
compared to wild-type (10), shows a midpoint around 50C,
whereas A53T has a midpoint around 57C. Both transition
temperatures are significantly lower than the 62C shown
by wild-type. It is reasonable to expect that the altered
membrane binding properties of the aSN mutant A30P and
the reported disruption of both mutants’ structure compared
to wild-type aSN (with concomitant reduced stability) will
affect these thermal transitions.
Fourth, we have also analyzed the dependence of this transi-
tion on the amount of lipid present (Fig. 3 A). The ellipticity
plateau between the two transitions increases with lipid concen-
tration up to around 0.5 mg/mL (i.e., 2.5 lipid/aSN w/w) after
which it remains constant (Fig. 3 B), indicating saturation
of binding. The data agree reasonably with the approximate
1.7 DMPG/aSN(w/w) binding ratio observed by EPR (30).
With increasing lipid concentration, the low- and high-temper-
ature transitions shift symmetrically away from each other,
respectively decreasing and increasing by around 6–8C
between 0.1 and 5 mg/mL lipid.
Finally, if we keep lipid concentration constant at 0.2 mg/mL
and vary protein concentration 20-fold between 0.05 and
1.0 mg/mL, we obtain the same two transitions in all cases,
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FIGURE 2 (A) Thermal far-UV CD scans of 0.2 mg/mL aSN in the absence of lipid and 0.2 mg/mL of the antimicrobial peptide Novispirin in 0.2 mg/mL
200 nm DMPG vesicles. (B) Thermal far-UV CD scans of 0.2 mg/mL aSN in 0.2 mg/mL 200-nm vesicles of DMPG in 10 mM sodium phosphate pH 7.4 and
0–600 mM NaCl (NaCl concentrations indicated in mM in the graph). (C) Transition temperatures for the first and second thermal transitions from (B), as well
as the molar ellipticity at 215 nm (in units of (deg cm2)/(dmol residue)) of the plateau level between the two transitions, plotted versus the square of the ionic
strength. Solid lines are best linear fits to the two transition temperature plots, whereas the stippled line is the best fit to the plateau plot. To minimize ambiguity,
we estimated the two sets of transition temperatures as follows: for the first transition, the temperature at which the transition starts (determined as the inter-
section between the preceding baseline and the first transition slope); for the second transition, the temperature at which the transition stops (determined as the
intersection between the second transition slope and the subsequent baseline). (D) Thermal far-UV CD scans of wild-type aSN and the two mutants A30P and
A53T in 0.2 mg/mL 200-nm DMPG vesicles. Protein concentration 0.2 mg/mL.although the low protein concentration at 0.05 mg/mL gives
a very small signal change and a broadening of the transition
(Fig. 3 C). The low-temperature transition occurs around
18C in all three cases, but there is a systematic shift upwards
in the high-temperature transition, which may be related to
stabilization of aSN by oligomerization (see below).
All these experiments illustrate that by using 0.2 mg/mL
lipid with 0.2 mg/mL protein, the aSN is in fact nicely placed
in the steepest part of a binding transition, so that even small
changes in the binding affinity (due to changes in the lipid
headgroup, chain length, ionic strength, etc.) are translatedinto large changes in the degree of folding. Importantly,
these observations strongly indicate that protein properties
rather than lipid artifacts dictate these transitions.
Anionic lipid is crucial for aSN binding
We also find that the amount of anionic lipid plays an important
role. In thermal scans ofaSN in mixed vesicles with increasing
concentrations of DMPC and decreasing concentrations of
DMPG, the high-temperature transition decreases drastically
to a midpoint around 34C in 80% DMPG and 28C in 60%Biophysical Journal 96(7) 2857–2870
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FIGURE 3 (A) Thermal far-UV CD scans of 0.2 mg/mL aSN in different concentrations of 200-nm DMPG vesicles. (B) Ellipticity at 215 nm of the scans in
(A) versus lipid concentration (solid circles) and midpoint of thermal transition (open circles), determined as the temperature at which ellipticity is half-way
between the preceding baseline level and the plateau level reached at the end of the transition. (C) Thermal far-UV CD scans of different concentrations of aSN
in 0.2 mg/mL 200-nm DMPG vesicles.DMPG, whereas the low-temperature transition remains
reasonably constant around 20C (Fig. 4 A). Thus the plateau
region between the two transitions shrinks and finally disap-
pears entirely at 40% DMPG and below, leading to a complete
absence of transition. Interestingly, when we replace DMPG
with the nonbilayer-forming lipid DMPE instead of DMPC,
the midpoint of the high-temperature transition is not lowered
so markedly as in DMPC, although the overall level of struc-
ture induction (the plateau after the low-temperature transition)
is reduced just as much as in DMPC (Fig. 4 B). A similar
reduction in structure induction and lowering of the high-
temperature transition has been reported in mixed vesicles of
DOPC, DOPG, and 1,2-Dioleoyl-sn-Glycero-3-Phosphoetha-
nolamine (DOPE) (37). Thus different zwitterionic headgroupsBiophysical Journal 96(7) 2857–2870appear to induce subtle changes in the types of interactions
between aSN and vesicles, in good accordance with the
suggestion that aSN is embedded in the upper part of the
membrane (34), and therefore the degree of binding of aSN,
and its consequent stabilization against unfolding, is sensitive
to the nature of the headgroup. However, changes in lipid
charge by addition of phosphocholine (PC) lipids shift the
plateau midpoint to lower temperatures (Fig. 4 A), because
the high-temperature transition is shifted down more than the
low-temperature transition. The shift is less pronounced if
we use phosphoethanolamine (PE) instead of PC lipids
(Fig. 4 B) and there are also subtle changes in the thermal
profile (compare 80% DOPG-20% DOPC in Fig. 4 A with
80% DOPG-20% DOPE in Fig. 4 B). Thus PE affects aSN
a-Synuclein Stability in Vesicles 2863A B
C
FIGURE 4 Thermal far-UV CD scans of 0.2 mg/mL aSN in 0.2 mg/mL 200-nm vesicles of mixtures of DMPG and (A) DMPC or (B) DMPE. The percent-
ages indicate the fraction of DMPG (w/w) in the lipid mixture. (C) Thermal far-UV CD scans of 0.2 mg/mL aSN in 0.2 mg/mL 200-nm vesicles of 1:1 mixtures
of different lipids.differently from PC in anionic lipids, consistent with the
specific role of PE lipids together with anionic lipids in forming
ion channels with well-defined conductance states in the pres-
ence of a transmembrane potential (37). The strongly reduced
binding of aSN to large vesicles in the liquid disordered phase
in the presence of PC presents a symmetric contrast to aSN’s
preference for small zwitterionic vesicles in the gel phase but
not liquid disordered phase (35). It clearly illustrates that there
are numerous combinations of vesicle size, state, and charge
that encourageaSN binding, revealing a complex energy land-
scape for protein-lipid interactions.
Given that aSN binding to small vesicles is encouraged
by lipid phase separation induced by the presence of lipids
of different chain lengths (19), we explored the effect of
different mixed vesicles. Although there are no clear thermaltransitions in neat DOPG (Fig. 1 B), the combination
DOPG-DMPG leads to two clear transitions (Fig. 4 C), of
which the first transition is shifted around 6C downwards
(to around 13–16C) compared to neat DMPG. Binary lipid
mixtures will typically show broad melting profiles contain-
ing peaks with individual peaks that do not coincide with
those of the pure components, but are shifted closer to
each other (41). In a DOPG-DMPG or DLPG-DMPG
mixture, we would therefore expect a major melting peak
6–8C below that of DMPG (tm 23C), i.e., around 15C
in good accordance with the observed transitions. The
DOPG-DLPG mixture, on the other hand, remains liquid
disordered throughout the scanned region and the transition
temperature is accordingly not affected compared to pure
DLPG.Biophysical Journal 96(7) 2857–2870
2864 Kjaer et al.A simple model to rationalize aSN behavior in
vesicles
To develop a framework that may qualitatively reproduce at
least some of the phenomena observed here, we develop
a simple model for aSN interactions with vesicles. Let us
consider the following simple binding scheme:
NL4
K1
DL4
K2
D þ L;
where L is lipid and NL and DL are the native (i.e., a-helix
rich) and denatured (intrinsically unstructured) protein,
respectively, embedded into the membrane. This scheme
can be further simplified by assuming that the surface
adsorbed denatured state does not exist, due to the high ener-
getic cost of burying unpaired hydrogen bond acceptors and
donors (found in D to a much greater extent than N) in an
amphiphilic environment (42):
NL4
K
D þ L:
We assume that aSN molecules bind independently and non-
cooperatively (as indicated by the hyperbolic binding curve
in Fig. 3 B).
From this we derive the following relationship:
½D
½NL ¼
co
½L exp

 DG
RT

¼ exp

 DG þ RTlnð½L=coÞ
RT

¼ exp

 DG þ DGconc
RT

; (1)
where co ¼1 mol/L is the standard state concentrations and
DG ¼ DGunfolding þ DGhydrophobic þ DGelectrostatic þ DGlipid.
The first two terms in this equation may be described by stan-
dard enthalpy and entropy terms according to Privalov (43),
whereas the third electrostatic term is treated according to
Heimburg and Marsh (44), and the fourth term is an entropic
term related to lipid concentration. This leads to the
following total equation:
DGtot ¼ DHo þ DcpðT  TmÞ  T

DHo
Tm
þ Dcpln T
Tm

þ 2Z ,RTln

Ko
sﬃﬃ
I
p

þ RTlnð½L=coÞ;
(2)
whereDHo is the enthalpy of unfolding,Dcp the heat capacity
difference between the folded and the unfolded state (which
we assume to be constant with temperature for simplicity),
Tm the unfolding temperature, Z is the effective charge of
the protein seen by the surface (assumed to be þ4 for aSN
by disregarding the C-terminal 45 residues that form an acidic
tail assumed to be away from the membrane (18)), s is the
charge density of the surface (for DMPG it is about one charge
(1.602  1019 C) per 50 A˚2, i.e., s ¼ 0.320), I is the ionicBiophysical Journal 96(7) 2857–2870strength, and Ko is an intrinsic constant whose size depends
on the magnitude of the hydrophobic and other nonelectro-
static contributions to binding. The strong linear correlations
between salt concentration and the transition temperatures as
well as plateau levels (Fig. 2C) support the inclusion of a term
for ionic strength.
When DGtot < 0, the protein is unfolded, when DGtot > 0
it is folded. The unfolding temperatures are found for
DGtot ¼ 0. Depending on the parameters in Eq. 2, one can
get zero, one, or two unfolding temperatures, representing
cold denaturation and hot denaturation, respectively. Cold
denaturation occurs upon lowering the temperature rather
than raising it; for simplicity we shall also refer to this
process as cold denaturation irrespective of the direction of
the temperature change. Cold denaturation arises from a posi-
tive value for Dcp, arising from the strong temperature
dependence of the interaction of water with apolar residues
of the peptide chain, which makes the exposure of apolar
amino acids to water favorable at low temperatures, thus trig-
gering unfolding upon cooling (45).
An additional factor needs to be taken into account. The
lipid phase transition appears to play an important role for
aSN’s ability to bind membranes, given that the low-
temperature transition coincides with tm (Fig. 1 B), and sup-
ported by the fact that the high-temperature transitions are
affected much more than the low-temperature transition by
changes in ionic strength, anionic lipid fraction, and lipid
concentration. The phase transition can easily be taken
into account by assuming that aSN only binds to the liquid
disordered phase, in good agreement with previous reports
(13,30). We can calculate the amount of fluid lipid as a func-
tion of temperature as follows. For a lipid with melting
point Tm, enthalpy of melting DHTm and cooperative unit
size, n, the equilibrium constant between fluid and gel
membrane is (41):
K ¼ exp
 
nDHTm

1  T
Tm

=RT
!
: (3)
The cooperative unit size describes how many lipids melt
simultaneously in a cluster or a domain and thus how narrow
the transition is. Typical values are n ¼ 100 for unilamellar
systems and n¼ 1000 for multilamellar systems. In addition,
we also consider the term a, which is the number of lipids
bound to each aSN molecule (which we estimate to be eight
on the basis of the saturation level at 2.5 lipid/aSN w/w in
Fig. 3 B). Thus in Eqs. 1 and 2, the lipid concentration [L]
can be replaced by the concentration of binding sites in the
fluid state, i.e., ([L]/a)  K/(1 þ K).
The equation successfully predicts most of our
experimental observations
To implement this equation, we use the following standard
values for the key parameters:
a-Synuclein Stability in Vesicles 2865DHo¼ 150 kJ/mol (lower than the 250 kJ/mol for e.g., the
membrane-binding protein cytochrome c (41) to reflect that
aSN is probably only partially folded in the membrane),
Tm
aSN ¼ 330 K (corresponding to the observed second
thermal transition around 57C), Dcp ¼ 6 kJ/mol/K (midway
between those of the two proteins cytochrome c (41) and
myoglobin (43), to reflect that aSN’s molecular weight is
midway between the two), Ko
el ¼ 0.1 mol/L, Z ¼ þ4 and
known values of DHTm and tm for the different lipids (see
legend to Fig. 5 A) Using these values, we can predict how
the thermal denaturation profile varies as a function of lipid
composition, ionic strength, and lipid concentration. The
values of these parameters are not fixed but are used to illus-
trate the predictive powers of our equation.
As seen in Fig. 5 A, the positions of the two thermal tran-
sitions correspond very well to the experimental data for
DPPG, DMPG, and DLPG, but not for DOPG (see below).
The slope of the first thermal transition (which reflects the
value of DHTm) increases with tm and thus chain length.
This increase is also observed when comparing the transition
in DMPG versus DPPG (Fig. 1 B).
Note that for DLPG (Tm 2C), we still observe a low-
temperature transition around 10–15C although the lipid
remains fluid throughout the measured temperature range.
DLPG thus illustrates that we can observe cold denaturation
of aSN at low lipid concentrations provided denaturation
occurs at temperatures above the lipid phase transition. Inter-
estingly, the same 10–15C transition is observed when we
use vesicles composed of 1:1 mixtures of DOPG-DLPG,
DOPG-DMPG, and DMPG-DLPG (Fig. 4 C). In the temper-
ature range between the melting points of the two lipid
components, these lipid mixtures will consist of two coexist-
ing phases, namely a liquid disordered phase consisting
mainly of the lipid with the lower melting temperature and
a gel phase with mainly the higher-melting lipid. Thus
aSN will undergo cold denaturation in these mixtures
provided there is some fluid phase present. Note that neat
DOPG is an anomaly, as the two experimentally observed
transitions in DOPG are very shallow and thus difficult to
assign to any specific structural transition. The maximum
amount of structure attained in DOPG is much lower than
that of the other lipids although DOPG remains in the liquid
disordered phase throughout the tested temperature range
(see further discussion below).
In our model, there is good correspondence between model
and data in the second transition, which shifts experimentally
by around 6–8C and 10–12C in the model. For the first tran-
sition, increasing DMPG concentration leads to a downward
shift in tm from 23.7
C to 23.0C (Fig. 5B) and a resulting shift
in the first transition by the same amount (Fig. 5C). This shift is
however much more modest than the experimentally observed
decrease in the first transition temperature from around 20C to
around 12C (Fig. 3B). If proteins only partition into the liquid
disordered phase, this will lead to freezing point depression
(46,47). Such a phenomenon will mainly occur at low lipid/protein ratios, in contrast to the observed trend. However, if
we assume that aSN can bind with equal affinity to both gel
phase and liquid disordered phase, we get a much more
pronounced shift in the low-temperature transition (data not
shown). This suggests that aSN in fact has a weak affinity
for the lipid gel phase that allows it to bind and undergo struc-
tural changes, provided sufficient lipid is present (41).
Electrostatics play a large role in the aSN-lipid interac-
tions. The effect of ionic strength, described in Eq. 2 is to
shift the first transition down by around 5C and the second
transition up by around 50C (Fig. 6 A), in remarkably good
agreement with data (Fig. 2 B). It is also possible to take the
lipid charge density into account in our model. If proteins
bind to a mixed lipid membrane (made of charged and
uncharged lipid), the charge density is lower and therefore
the binding is weaker. If the lipids mix ideally, then the
binding of the protein may lead to an accumulation of the
charged lipid underneath the protein. Under these condi-
tions the intrinsic binding constant Ko in Eq. 2 has to be re-
placed by a term that contains the fraction of charged lipid,
fA, the relative association constant, Kr, of the charged lipid
to the protein (as compared to the uncharged lipid), and the
area occupied by a protein molecule on the membrane
surface relative to that of a single lipid molecule, a. As
described in detail elsewhere (48), this leads to the
following term:
K0/Ko
f 2ZA ð1  fA þ fAKrÞa
Kfaar
: (4)
With standard values (a ¼ 8 and Kr ¼ 4.8) used for cyto-
chrome binding to lipid membranes (44,48), we observe
(Fig. 6 B) that as the fraction of charged lipid decreases, so
there is a reduction in the degree of folding in the intermediate
regime between the two transitions. At a charge fraction
fA ¼ 0.6, folding has practically disappeared. As seen for
changes in ionic strength, the high-temperature transition
is affected much more strongly than the low-temperature
transition.
Thermal scans at different aSN concentrations (Fig. 3 C)
reveal that the high-temperature transition is shifted upwards
at higher protein concentrations. This indicates that associa-
tion or aggregation of aSN on the membrane stabilizes the
protein against thermal unfolding, which is in good agreement
with previous reports that membranes stimulateaSN aggrega-
tion (20,49). For simplicity, we have not included this aspect
in our model. The oligomerization may be modeled in
numerous ways and may in fact lead to a continuum of
different species, about which our limited data cannot provide
more detailed information. More systematic future studies
may shed further light on this.
Observations not addressed by the model
Thus our simple model captures most of our data. However,
two aspects have not been addressed:Biophysical Journal 96(7) 2857–2870
2866 Kjaer et al.Different degrees of structure induced in different lipids
It is clear from Fig. 1 B (and insert) that the higher the lipid-
melting temperature, the higher the proportion of aSN that is
folded (measured as the ellipticity plateau level between the
two thermal transitions). Based on the titration in Fig. 3, we
can estimate that only up to 50% of aSN is bound to lipid in
Fig. 1 B. Thus under these conditions we are in the middle of
the binding transition, making binding very sensitive to
A 
B 
C 
FIGURE 5 Predicted behavior of aSN when heated in the presence of different concentrations of anionic lipid, based on Eq. 2 (including lipid thermal tran-
sitions). (A) Thermal transitions in different lipids, depicted as the fraction unfolded protein as a function of temperature (0.2 mg/mL protein and 0.2 mg/mL
lipid in 160 mM ionic strength). The following melting enthalpies DHTm and melting temperatures tm were used: DPPG: DH ¼ 35 kJ/mol, tm ¼ 41.2C;
DMPG: DH ¼ 24 kJ/mol, tm ¼24C; DLPG: DH ¼ 13 kJ/mol, tm ¼ 2C. For DOPG (tm ¼ 20C), the lipid was considered fluid in the whole temperature
range. The unit of cooperativity n was set to 100, which is typical of unilamellar systems such as those used here. Values for DMPG and DPPG have been offset
by 0.1 and 0.2 units on the y axis for clarity. Values for DOPG and DLPG are identical given that they are both fluid in the temperature range where aSN
undergoes cold denaturation (>0C). (B) Heat capacity changes and (C) corresponding degree of folding of aSN (0.2 mg/mL protein and 160 mM ionic
strength) as a function of DMPG concentration. The heat capacity changes contain contributions both from the DMPG phase transition (highlighted in the
insert to (B)) and from aSN folding/unfolding.Biophysical Journal 96(7) 2857–2870
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different lipids in Fig. 1 B is the same (0.2 mg/mL) in all
cases, we conclude that aSN has higher affinity for the liquid
disordered phase in higher-melting lipids. It is not a simple
matter of increased affinity at higher temperatures, given
that aSN passes through the same temperature range in all
lipids. Instead the explanation must be found in intrinsic lipid
properties.
The lipid-melting transition is characterized by a sharp
peak in the heat capacity Dcp. The heat capacity scales
directly with several mechanical properties of the bilayer,
which also show a maximum around tm, including elastic
B 
A 
FIGURE 6 (A) Predicted effect of different ionic strength on the temper-
ature-dependent folding of 0.2 mg/mL aSN in 0.2 mg/mL DMPG. Insert
shows the change in the degree of folding of aSN as a function of temper-
ature. (B) Predicted effect of the reduction in the fraction of anionic lipid
(w/w) on the aSN thermal transitions.area compressibility (50), the volume expansion coefficient
(51), and permeability (52). This maximum is due to the
dynamic heterogeneity in this temperature range owing to
coexisting domains of gel phase and liquid disordered phase
(52). It can be envisaged that the interfacial regions of these
domains provide good binding sites for the binding of proteins
as well as small nonpolar solutes such as alcohols and fatty
acids (53). These properties will also depend on the chain
length and tm. The higher the tm, the narrower and taller the
DCp peak and, in parallel, the compressibility. Yet this
chain-length dependent difference in maximum compress-
ibility/permeability only occurs in a narrow temperature range
and should not affect lipid properties in regimes outside the
transition region. aSN does not have to be heated up in the
presence of lipids through the transition region to fold but
can insert directly into the fluid disordered phase well above
tm (data not shown). Nevertheless, the phenomenon leads to
a linear relationship between the proportion of folded aSN
and the lipid-melting temperature, and thus provides an
empirical explanation for DOPG’s low ability to induce struc-
ture in aSN, namely its low tm (20C).
The dependence on vesicle size
It is intriguing that the induction of structure requires vesicles
above a certain size. In other words, if the curvature increases
beyond a certain threshold, no significant binding occurs.
The reliance on large rather than small vesicles runs counter
to many of the other examples of curvature-sensitive proteins
(35,54–56), which show a lesser degree of folding, activity, or
binding when exposed to larger vesicle sizes. In these latter
cases, it is thought that cracks or defects in the vesicle surface
induced by curvature will provide sites for proteins to bind.
These defects also make small vesicles inherently unstable.
On standing, particularly below the tm, they tend to coalesce
to vesicles which for DPPC are around 70 nm in size (57), but
other phosphatidylcholine vesicles have also been measured to
be around 140 nm (58), which is also the minimum size
required to induce significant amounts of aSN binding
(Fig. 1 D). To our knowledge, no data exist for phosphatidyl-
glycerol vesicles, but it seems reasonable to assume that they
will assume the same size optimum. Interestingly, smaller
vesicles show broader thermal transitions and a lower maximal
Dcp than larger vesicles (59). This is similar to the difference
between low-melting lipids and high-melting lipids. Also in
this case, higher maximal Dcp values translate into a larger
degree of structure for aSN for lipids with higher melting
temperatures, although the Dcp spike is confined to the transi-
tion region. We are at present unable to point to any lipid prop-
erties that can explain how these empirical observations may
affect lipid properties above the transition region. For example,
lateral pressure profiles do not place DOPG in a group apart
from the other lipids measured in this study (60).
Our data may appear to contradict previous work that indi-
cates binding of aSN to small unilamellar vesicles (SUVs);
however, that work is typically carried out at much higherBiophysical Journal 96(7) 2857–2870
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number of binding sites is not limited. The low lipid/protein
ratios used by us magnifies any differences between affinities
for different lipid sizes. It should also be pointed out that we
do not exclude formation of some a-helical structure but
rather highlight that vesicle size (whose effect on aSN
binding has not previously been systematically probed to
our knowledge) may influence the extent of this structural
formation and its subsequent loss by thermal denaturation.
We should also point out that the occasional deviation
from size reliance that we observe in our thermal scans
may reflect variations in vesicle size homogeneity and struc-
ture that can lead to altered vesicle affinity by aSN. It is well
known that vesicle preparations can vary in terms of size
distribution and stability against coalescence, and such small
variations can affect the binding affinity. However, the
unmistakable trend in our observations, measured for
numerous different lipids, is a clear separation between the
effects of small and large vesicles.
Although our data do not provide clear explanations for
the size-dependence, various hypotheses can be proposed.
A very recent report by Eliezer and co-workers provides
strong evidence from pulsed electron spin resonance (ESR)
data that aSN forms an extended helix at least 7 nm long
in the presence of vesicles (containing 50% anionic lipids
and 50% zwitterionic lipids) and bicelles (23). Similar results
were obtained by the Langen group using continuous-wave
ESR (24). The uninterrupted a-helical stretch makes the
protein potentially sensitive to vesicle curvature, neverthe-
less the structure of aSN could easily be fitted onto the
curved surface of a small 30-nm vesicle (24). Intermolecular
interactions between individual extended helices could in
principle exacerbate the sensitivity to vesicle size; however,
such intermolecular contacts were not reported. It should be
noted that aSN may form broken or antiparallel helices under
very similar conditions according to other recent ESR studies
in conjunction with molecular simulations (25,26), making it
difficult to make firm conclusions on how this impacts on the
size-dependence. Another possibility is that nonhelical struc-
tures can be stabilized by packing defects in strongly curved
vesicles; note though that such packing defects tend to be
most pronounced for very small vesicles (30 nm diameter),
well below the ~100-nm threshold we observe. Furthermore,
simple energy considerations, such as the need for internal
hydrogen bonding in an environment with reduced water
accessibility (42), suggest that aSN must adopt some
nonrandom coil structure when it binds to the lipid surface.
We have no evidence that aSN adopts other types of
secondary structure in the presence of lipids on the short
time scales of our experiments in this report.
Implications for the biological function of aSN
Our data thus illustrate that aSN vesicle binding is strongly
modulated by lipid properties as well as its intrinsic ability toBiophysical Journal 96(7) 2857–2870form a-helical structures in an anionic lipid environment.
There are numerous quite different optimal aSN binding
conditions. Our observations illustrate that aSN prefers the
liquid disordered phase of large anionic vesicles, but other
reports detail that aSN can also bind to and fold on small
zwitterionic vesicles in the gel phase (35). In the presence
of lipid rafts, aSN binding requires anionic lipids (preferen-
tially containing a polyunsaturated acyl chain and a phospha-
tidylserine headgroup) and the coexistence of different
domains (19). Although the structure is a-helical in all cases,
we cannot exclude that there are subtle changes in the orien-
tation of the protein, e.g., peripheral versus partially inserted
versus transmembrane (37).
It is possible that these structural variations and their
dependence on vesicle size may have biological significance.
It has been suggested that aSN affects the distal pool of
synaptic vesicles (6,61). Synaptic vesicles are close to their
transition temperature, meaning that binding is optimal,
and aSN could modulate the structure of these lipids or
simply select those above a certain size by binding to them
and chaperoning them to the cell membrane. aSN may
have a negative regulatory role in neurotransmission (62),
by e.g., inhibiting docking of synaptic vesicles at active
zones of SNARE complexes, possibly by stabilizing them
at a size that prevents fusion with SNARE complexes
(63,64). This role is confirmed by the observation in yeast
that mutants impaired in vesicular trafficking were more
sensitive to aSN expression (7), and conversely overexpres-
sion of proteins participating in vesicular transport between
the ER and Golgi could suppress aSN toxicity (8). The
aSN defect probably occurs at the stage of vesicle teth-
ering/docking/fusion at the Golgi (8), in accordance with
the pivotal role of aSN-vesicle interactions.
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